OPIS, a leading Clinical Research Organization (CRO), announces its strategic partnership with FindMeCure's TrialHub, a cutting-edge clinical trial planning platform. Through this collaboration, OPIS is committed to fostering patient empowerment and education by donating a full patient scholarship to the EUPATI Patient Expert Programme.
In the dynamic landscape of clinical research, patient-centricity has emerged as a central pillar of success. OPIS recognizes the pivotal role that patients play in shaping the future of healthcare, and this partnership underscores the company’s unwavering commitment to placing patients at the heart of clinical trials.
By contributing to the EUPATI Patient Expert Programme, OPIS aims to empower patients with knowledge, enabling them to become active participants in the clinical research process. This initiative aligns with OPIS's core values of transparency, inclusivity, and innovation.
EUPATI, the European Patients' Academy on Therapeutic Innovation, has been at the forefront of empowering patients to be active partners in the drug development process. The Patient Expert Programme provides comprehensive training to patients interested in contributing their unique perspectives to the world of clinical research.
"The patients’ voice is more and more important in clinical research," said Barbara Panzeri at OPIS. "To have the opportunity to design trials listening to the patients could be an additional value for the pharmaceutical companies and CROs like ours”.
TrialHub, a pioneer in patient-centric clinical trial solutions, is honored to partner with OPIS in this groundbreaking endeavor. Together, they are poised to drive positive change and empower patients to be active stakeholders in the clinical research process.
Founded in 1998 by medical experts with pharmaceutical industry knowledge, OPIS is a prominent global clinical CRO with 25 years of experience in various therapeutic areas. We provide comprehensive clinical trial support from concept development to project execution, data analysis, and reporting. Our services encompass Phase I-IV trials, interventional, non-interventional, and medical device studies worldwide. We also excel in pre- and post-marketing clinical investigations for medical, diagnostic, nutraceutical, and food supplement studies. OPIS is dedicated to delivering full-service solutions for successful clinical trials and medical research.
TrialHub is an NLP and AI-powered data intelligence platform dedicated to empowering clinical trial strategists with real-time insights on sites, competition, patients and regulations. Thanks to thousands of validated data sources and the latest Generative AI capabilities we are able to answer any question thus ensuring knowledge across teams and data-driven decision making towards more successful and patient-friendly clinical trials. Visit trialhub.com to learn more.